Ultragenyx Pharmaceutical Inc
F:UP0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Ultragenyx Pharmaceutical Inc
F:UP0
|
US |
|
R
|
Rockwell Automation Inc
F:RWL
|
US |
|
Kimberly-Clark de Mexico SAB de CV
F:4FX0
|
MX |
|
S
|
Sino Land Co Ltd
XMUN:SNO
|
HK |
|
Recruit Holdings Co Ltd
TSE:6098
|
JP |
|
Hong Kong Exchanges and Clearing Ltd
F:HK2
|
HK |
|
E
|
Equifax Inc
SWB:EFX
|
US |
|
E
|
EssilorLuxottica SA
MIL:EL
|
FR |
|
C
|
Ctac NV
F:TAC
|
NL |
Wall St Price Targets
UP0 Price Targets Summary
Ultragenyx Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for UP0 is 61.39 EUR with a low forecast of 31.53 EUR and a high forecast of 116.54 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UP0's stock price target?
Price Target
61.39
EUR
According to Wall Street analysts, the average 1-year price target for UP0 is 61.39 EUR with a low forecast of 31.53 EUR and a high forecast of 116.54 EUR.
What is the Revenue forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
23%
The compound annual growth rate for Revenue over the next 8 years is 23%.
What is the Gross Profit forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
23%
The compound annual growth rate for Gross Profit over the next 7 years is 23%.
